Cargando…
Metformin is Associated with Reduced COVID-19 Severity in Patients with Prediabetes
BACKGROUND: With the continuing COVID-19 pandemic, identifying medications that improve COVID-19 outcomes is crucial. Studies suggest that use of metformin, an oral antihyperglycemic, is associated with reduced COVID-19 severity in individuals with diabetes compared to other antihyperglycemic medica...
Autores principales: | Chan, Lauren E., Casiraghi, Elena, Laraway, Bryan, Coleman, Ben, Blau, Hannah, Zaman, Adnin, Harris, Nomi, Wilkins, Kenneth, Gargano, Michael, Valentini, Giorgio, Sahner, David, Haendel, Melissa, Robinson, Peter N., Bramante, Carolyn, Reese, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460973/ https://www.ncbi.nlm.nih.gov/pubmed/36093353 http://dx.doi.org/10.1101/2022.08.29.22279355 |
Ejemplares similares
-
Metformin is associated with reduced COVID-19 severity in patients with prediabetes
por: Chan, Lauren E., et al.
Publicado: (2022) -
Increased risk of psychiatric sequelae of COVID-19 is highest early in the clinical course
por: Coleman, Ben, et al.
Publicado: (2021) -
Risk of new‐onset psychiatric sequelae of COVID‐19 in the early and late post‐acute phase
por: Coleman, Ben, et al.
Publicado: (2022) -
Predictive models of long COVID
por: Antony, Blessy, et al.
Publicado: (2023) -
Generalisable long COVID subtypes: Findings from the NIH N3C and RECOVER programmes
por: Reese, Justin T., et al.
Publicado: (2022)